Substance P up-regulates matrix metalloproteinase-1 and down-regulates collagen in human lung fibroblast

Experimental Lung Research

Volumn 33, Issue 3-4, 2007, Pages 151-167

  Ramos, Carlos ^a   Montaño, Martha ^a   Cisneros, Jose ^a   Sommer, Bettina ^a   Delgado, Javier ^a   Gonzalez Avila, Georgina ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Collagen; Fibroblasts; MMP 1; Substance P

Indexed keywords

COLLAGEN; GELATINASE A; INTERSTITIAL COLLAGENASE; MESSENGER RNA; SUBSTANCE P; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CASE REPORT; CELL METABOLISM; CELL STRAIN; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; LUNG FIBROBLAST; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; CHILD, PRESCHOOL; COLLAGEN; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INDUCTION; FEMALE; FIBROBLASTS; HUMANS; LUNG; MALE; MATRIX METALLOPROTEINASE 1; RECEPTORS, NEUROKININ-1; RNA, MESSENGER; SUBSTANCE P; TRYPTOPHAN;

EID: 34250218548     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902140701364409     Document Type: Article

References (35)

1. Parks WC: Matrix metalloproteinases in lung repair. Eur Respir J. 2003;22:(Suppl. 44):36S-38S.
2. Chirco R, Liu X-W, Jung K-K, Kim HR: Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev. 2006;25:99-113.
3. Barnes PJ: Mechanisms in COPD: Differences from asthma. Chest. 2000;117:10S-14S.
4. Harrison S, Geppetti P: Substance P. Int J Biochem Cell Biol. 2001;33:555-576.
5. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F: The role of substance P in inflammatory disease. J Cell Physiol. 2004;201:167-180.
6. Joos GF, De Swert KO, Schelfhout V, Pauwels RA: The role of neural inflammation in asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci. 2003;992:218-230.
7. Myers AC, Kajekar R, Undem BJ: Allergic inflammation-induced neuropeptide production in rapidly adapting afferent nerves in guinea pig airways. Am J Physiol Lung Cell Mol Physiol. 2002;82:L775-L781.
8. Joad JP, Munch PA, Bric JM, Evans SJ, Pinkerton KE, Chen C-Y, Bonham AC: Passive smoke effects on cough and airways in young guinea pigs: role of brainstem substance P. Am J Respir Crit Care Med. 2004;169:499-504.
9. Wu Z-X, Satterfield BE, Dey RD: Substance P released from intrinsic airway neurons contributes to ozone-enhanced airway hyperresponsiveness in ferret trachea. J Appl Physiol. 2003;95:742-750.
10. Hope-Gill BDM, Hilldrup S, Davies C, Newton RP, Harrison NK: A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;68:995-1002.
11. Howarth PH, Dukanovic R, Wilson JW, Holgate ST, Springall DR, Polak JM: Mucosal nerves in endobronchial biopsies in asthma and non-asthma. Int Arch Allergy Appl immunol. 1991;94:330-333.
12. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G: Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and allergic asthma. J Allergy Clin Immunol. 1992;90:646-652.
13. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, Shirato K: Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med. 1995;151(3 Pt 1):613-617.
14. Takeyama M, Nagai S, Mori K, Ikawa K, Satake N, Izumi T: Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13:33-37.
15. Lotz M, Carson DA, Vaughan JH: Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science. 1987;20:235:893-895.
16. Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ: Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol. 1993;110:43-49.
17. Ramos C, Montano M, Garcia-Alvarez J, Ruiz V, Uhal BD, Selman M, Pardo A: Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinase expression. Am J Respir Cell Mol Biol. 2001;24:591-598.
18. Wang R, Ramos C, Joshi I, Zagariya A, Pardo A, Selman M, Uhal BD: Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin. Am J Physiol Lung Cell Mol Physiol. 1999;277:L1158-L1164.
19. Castro-Obregon S, Del Rio G, Chen SF, Swanson RA, Frankowski H, Rao RV, Stoka V, Vesce S, Nicholls DG, Bredesen DE: A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ. 2002;9:807-817.
20. Selman M, Gonzalez G, Bravo M, Sullivan-Lopez J, Ramos C, Montano M, Barquin N, Vadillo F: Effect of lung T lymphocytes on fibroblasts in idiopathic pulmonary fibrosis and extrinsic allergic alveolitis. Thorax. 1990;45:451-455.
21. Gonzalez-Avila G, Iturria C, Vadillo-Ortega F, Ovalle C, Montano M: Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model. Pathobiology. 1998;66:196-204.
22. Vadillo-Ortega F, Gonzalez-Avila G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Stauss JF III: 92 kD type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol. 1995;146:148-156.
23. Becerril C, Pardo A, Montano M, Ramos C, Ramirez R, Selman M: Acidic fibroblast growth factor induces an antifibrogenic phenotype in human lung fibroblasts. Am J Respir Cell Mol Biol. 1999;20:1020-1027.
24. Selman M, King TE, Pardo A: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134:136-151.
25. Kahler CM, Sitte BA, Reinisch N, Wiedermann CJ: Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol. 1993;249:281-286.
26. Kahler CM, Pischel A, Kaufmann G, Wiedermann CJ: Influence of neuropeptides on neutrophil adhesion and transmigration through a lung fibroblast barrier in vitro. Exp Lung Res. 2001;27:25-46.
27. Parenti A, Amerini S, Ledda F, Maggi CA, Ziche M: The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol. 1996;353:475-481.
28. Liu JY, Hu JH, Zhu QG, Li FQ, Sun HJ: Substance P receptor expression in human skin keratinocytes and fibroblasts. Br J Dermatol. 2006;155:657-662.
29. Gryszkiewicz M: The effect of substance P on collagen concentration in rat colon. Pol Merkuriusz Lek. 1997;3:245-247.
30. Katayama I, Nishioka K: Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. J Dermatol Sci. 1997;15:201-206.
31. O'Connor TM, O'Connell J, Darren I, O'Brien, Bennett MW, Goode T, Burke L, Bredin CP, ShanahanF: Upregulation of neurokinin-1 receptor expression in the lungs of patients with sarcoidosis. Clin Immunol. 2003;23:425-435.
32. Bowden JJ, Garland AM, Baluk P, Lefevre P, Grady EF, Vigna SR, Bunnett NW, McDonald DM: Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA. 1994;91:8964-8968.
33. D'Ortho MP, Jarreau PH, Delacourt C, Pezet S, Lafuma C, Harf A, Macquin-Mavier I: Tachykinins induce gelatinase production by guinea pig alveolar macrophages: involvement of NK2 receptors. Am J Physiol. 1995;269:L631-L636.
34. Partsch G, Matucci-Cerinic M, Marabini S, Jantsch S, Pignone A, Cagnoni M: Collagenase synthesis of rheumatoid arthritis synoviocytes: dose-dependent stimulation by substance P and capsaicin. Scand J Rheumatol. 1991;20:98-103.
35. Hecker-Kia A, Kolkenbrock H, Orgel D, Zimmermann B, Sparmann M, Ulbrich N: Substance P induces the secretion of gelatinase A from human synovial fibroblasts. Eur J Clin Chem Clin Biochem. 1997;35:655-660.